PROCEPT BioRobotics Corporation (PRCT) Financials
PRCT Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-03-31 | 382.9 million | 118.9 million |
| 2023-12-31 | 404.7 million | 124.0 million |
| 2023-09-30 | 421.1 million | 121.8 million |
| 2023-06-30 | 272.4 million | 116.5 million |
PRCT Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-03-31 | -34.2 million | ? |
| 2023-12-31 | -33.5 million | 5.0 million |
| 2023-09-30 | -24.7 million | 5.3 million |
| 2023-06-30 | -33.7 million | 5.1 million |
PRCT Net Income
No data available :(
PRCT Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-03-31 | 225.6 million | - | - |
| 2023-12-31 | 257.2 million | - | 27.9 million |
| 2023-09-30 | 287.1 million | - | 28.4 million |
| 2023-06-30 | 149.7 million | 51.3 million | 29.5 million |
PRCT Shares Outstanding
PRCT Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-03-31 | 1.9 million | 13.1 million | - | - |
| 2023-12-31 | 8.7 million | 13.2 million | 36.3 million | - |
| 2023-09-30 | 5.8 million | 11.6 million | 32.9 million | - |
| 2023-06-30 | 5.4 million | 11.6 million | 32.4 million | - |
PRCT Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-03-31 | 44.5 million | 19.5 million |
| 2023-12-31 | 43.6 million | 23.6 million |
| 2023-09-30 | 35.1 million | 16.2 million |
| 2023-06-30 | 33.1 million | 14.7 million |
PRCT
Price: $64.31
52 week price:
Earnings Per Share: -2.24 USD
P/E Ratio: -20.70
Exchange: NGM
Sector: Healthcare
Industry: Medical Devices
Volume: 249300
Market Capitalization: 3.3 billion